This inventor holds 5 USPTO granted patents, plus 2 CIPO patents and 4 EPO patents. Top assignees: Genome Pharmaceuticals Institute Co., Ltd., Imagine Global Care Corporation, The University of Tokyo. Active years: 2012-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 3 
3 out of 3 
3 out of 1,358 
Years Active: 2012-2025
Title: The Innovations of Kazuhisa Sekimizu: Pioneering Innate Immunity Research
Introduction: Kazuhisa Sekimizu, a prominent inventor based in Tokyo, Japan, has made significant contributions to the field of innate immunity through his innovative research. With a total of four patents credited to his name, Sekimizu's work is vital in enhancing our understanding of immune responses and potential therapeutic applications.
Latest Patents: One of Sekimizu's latest patents focuses on a polysaccharide that has innate immunity stimulating activity. This polysaccharide consists of various constituent sugars, including 25 to 50 parts by mole of galacturonic acid, 15 to 50 parts by mole of galactose, and smaller amounts of glucose, arabinose, xylose, and rhamnose. The unique structure features a polygalacturonic acid chain composed primarily of α-1,4-linked galacturonic acid. The implications of this research suggest that this polysaccharide could serve as an active component in immunostimulatory food and drinks. Additionally, Sekimizu's work on lactic acid bacteria, known for their natural immune activation capabilities, further underscores his innovative approach to infection prevention and therapeutic treatments.
Career Highlights: Throughout his career, Kazuhisa Sekimizu has been associated with prestigious institutions such as the Genome Pharmaceuticals Institute Co., Ltd. and The University of Tokyo. At these organizations, he has collaborated on various research projects aimed at enhancing human health through immune system advancements.
Collaborations: Sekimizu has worked alongside notable coworkers, including Hiroshi Hamamoto and Kazuhisa Murakami. Their collaborations have further propelled the progress in innate immunity research, facilitating the development of new methodologies and applications within the healthcare sector.
Conclusion: Kazuhisa Sekimizu's inventive spirit and commitment to advancing our understanding of innate immunity have led to significant innovations in the field. His patents reflect a dedication to improving human health through scientific exploration. As the landscape of immunology continues to evolve, Sekimizu's contributions will undoubtedly play a crucial role in shaping future therapies and health solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile